The Pharmaceuticals Industry in the Health Care Sector includes companies engaged in the research, development, or production of pharmaceuticals (including veterinary drugs).
The Pharmaceuticals industry index is a market composite index that includes 15 stocks from public trading companies and ADRs with the largest market capitalizations in the Pharmaceuticals industry.
The list of stocks in the Pharmaceuticals industry includes Roche Holding AG, Novartis AG, Astrazeneca PLC, Johnson & Johnson, Pfizer Inc, Embecta Corp, Roche Holding AG, Glaxosmithkline PLC, Viatris Inc., Zoetis Inc, Merck & Co Inc, Eli Lilly and Co, Sanofi, Bristol-Myers Squibb Co and Novo Nordisk A/S.
Roche Holding AG (RHHBF) |
+1.38%
|
Novartis AG (NVS) |
+1.24%
|
Astrazeneca PLC (AZN) |
+1.13%
|
Johnson & Johnson (JNJ) |
+0.80%
|
Pfizer Inc (PFE) |
+0.56%
|
Embecta Corp (EMBC) |
+0.43%
|
Roche Holding AG (RHHBY) |
+0.43%
|
Glaxosmithkline PLC (GSK) |
+0.36%
|
Viatris Inc. (VTRS) |
+0.24%
|
Zoetis Inc (ZTS) |
+0.24%
|
Pharmaceuticals Industry |
-0.62%
|
Merck & Co Inc (MRK) |
-1.00%
|
Eli Lilly and Co (LLY) |
-1.01%
|
Sanofi (SNY) |
-1.11%
|
Bristol-Myers Squibb Co (BMY) |
-2.29%
|
Novo Nordisk A/S (NVO) |
-2.79%
|
Symbol | Security | Price | Gain | Volume | vol. Str. | Weight |
RHHBF | Roche Holding AG | 335.06 | +1.38% | 11 | N/A | 0.00% |
NVS | Novartis AG | 106.82 | +1.24% | 1.49M | 1.12 | 7.43% |
AZN | Astrazeneca PLC | 72.66 | +1.13% | 6.12M | 1.27 | 7.94% |
JNJ | Johnson & Johnson | 154.24 | +0.80% | 4.67M | 0.59 | 13.13% |
PFE | Pfizer Inc | 25.88 | +0.56% | 31.26M | 0.78 | 5.20% |
EMBC | Embecta Corp | 17.50 | +0.43% | 554,539 | 1.44 | 0.04% |
RHHBY | Roche Holding AG | 39.94 | +0.43% | 890,855 | N/A | 0.01% |
GSK | Glaxosmithkline PLC | 36.46 | +0.36% | 4.20M | 0.95 | 2.64% |
VTRS | Viatris Inc. | 10.62 | +0.24% | 7.36M | 0.89 | 0.45% |
ZTS | Zoetis Inc | 171.84 | +0.24% | 2.12M | 0.92 | 2.76% |
Pharmaceuticals Industry | 23,693.08 | -0.62% | 2.96B | 0.92 | 42.24% | |
MRK | Merck & Co Inc | 86.41 | -1.00% | 17.48M | 1.52 | 7.87% |
LLY | Eli Lilly and Co | 869.23 | -1.01% | 2.47M | 0.70 | 29.70% |
SNY | Sanofi | 53.32 | -1.11% | 1.48M | 0.65 | 4.79% |
BMY | Bristol-Myers Squibb Co | 55.55 | -2.29% | 13.79M | 1.37 | 4.11% |
NVO | Novo Nordisk A/S | 83.92 | -2.79% | 9.22M | 1.16 | 13.95% |
Symbol | Security | Market Cap | Div Yield | PEG Ratio |
RHHBF | Roche Holding AG | 230.427B | 3.06% | |
NVS | Novartis AG | 206.465B | 3.80% | |
AZN | Astrazeneca PLC | 197.819B | 4.69% | |
JNJ | Johnson & Johnson | 368.366B | 3.14% | |
PFE | Pfizer Inc | 142.241B | 6.72% | |
EMBC | Embecta Corp | 788.608M | 4.16% | |
RHHBY | Roche Holding AG | 229.264B | 26.89% | |
GSK | Glaxosmithkline PLC | 68.267B | 1.81% | |
VTRS | Viatris Inc. | 15.576B | 3.69% | |
ZTS | Zoetis Inc | 79.207B | 0.95% | |
Pharmaceuticals Industry | $53.32T | 3.19% | 18.39 | |
MRK | Merck & Co Inc | 244.211B | 3.15% | |
LLY | Eli Lilly and Co | 710.844B | 0.69% | |
SNY | Sanofi | 120.344B | ||
BMY | Bristol-Myers Squibb Co | 118.101B | 4.23% | |
NVO | Novo Nordisk A/S | 458.578B | 9.92% |